18-methoxycoronaridine
- Generic Name
- 18-methoxycoronaridine
- Drug Type
- Small Molecule
- Chemical Formula
- C22H28N2O3
- CAS Number
- 308123-60-6
- Unique Ingredient Identifier
- KX8NQX91Z8
- Background
18-methoxycoronaridine is under investigation in clinical trial NCT03084952 (Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients).
Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients
Phase 2
- Conditions
- Drug Side EffectLeishmaniasis; American, Cutaneous
- Interventions
- First Posted Date
- 2017-03-21
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Infan Industria Quimica Farmaceutica Nacional
- Target Recruit Count
- 52
- Registration Number
- NCT03084952
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath